CN1859918B - 透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用 - Google Patents

透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用 Download PDF

Info

Publication number
CN1859918B
CN1859918B CN2004800282820A CN200480028282A CN1859918B CN 1859918 B CN1859918 B CN 1859918B CN 2004800282820 A CN2004800282820 A CN 2004800282820A CN 200480028282 A CN200480028282 A CN 200480028282A CN 1859918 B CN1859918 B CN 1859918B
Authority
CN
China
Prior art keywords
hyaluronic acid
kda
around
soft tissue
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2004800282820A
Other languages
English (en)
Chinese (zh)
Other versions
CN1859918A (zh
Inventor
罗伯特·约翰·佩特雷拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1859918A publication Critical patent/CN1859918A/zh
Application granted granted Critical
Publication of CN1859918B publication Critical patent/CN1859918B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN2004800282820A 2003-10-09 2004-08-27 透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用 Expired - Lifetime CN1859918B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51068403P 2003-10-09 2003-10-09
US60/510,684 2003-10-09
PCT/CA2004/001579 WO2005032562A1 (en) 2003-10-09 2004-08-27 Methods for treating acute and overuse sprain and strain using hyaluronic acid

Publications (2)

Publication Number Publication Date
CN1859918A CN1859918A (zh) 2006-11-08
CN1859918B true CN1859918B (zh) 2010-07-07

Family

ID=34421822

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800282820A Expired - Lifetime CN1859918B (zh) 2003-10-09 2004-08-27 透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用

Country Status (14)

Country Link
US (1) US20050080037A1 (enExample)
EP (1) EP1677806B1 (enExample)
JP (4) JP2007507431A (enExample)
CN (1) CN1859918B (enExample)
AT (1) ATE414522T1 (enExample)
AU (1) AU2004277290B2 (enExample)
CA (1) CA2541813C (enExample)
DE (1) DE602004017888D1 (enExample)
DK (1) DK1677806T3 (enExample)
ES (1) ES2317018T3 (enExample)
PL (1) PL1677806T3 (enExample)
PT (1) PT1677806E (enExample)
SI (1) SI1677806T1 (enExample)
WO (2) WO2005032562A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2744999A1 (en) * 2004-12-30 2006-07-13 Genzyme Corporation Regimens for intra-articular viscosupplementation
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
EP1968614A2 (en) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
DE602006008834D1 (de) * 2006-05-11 2009-10-08 Sandra Gobbo Binäre hyaluronsäure-gemische und ihre therapeutische verwendung
US9072779B2 (en) 2009-01-07 2015-07-07 Robert John Petrella Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
ES2665254T3 (es) 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
AU2013374192B2 (en) * 2013-01-17 2018-11-08 Damian NAQVI Increasing muscular volume in a human using hyaluronic acid
CN106860706A (zh) * 2015-12-10 2017-06-20 仲伟波 双液删刺药液
RU2018141386A (ru) * 2016-04-27 2020-05-27 Аника Терапьютикс, Инк. Композиция для применения в лечении дегенерации сухожилий
WO2025096427A1 (en) * 2023-10-29 2025-05-08 Brown David Donaldson Methods for treating lower back pain with hyaluronic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041724A1 (en) * 2001-11-13 2003-05-22 Alcon, Inc. Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
WO2004034980A2 (en) * 2002-10-16 2004-04-29 Marcum Frank D Treatment for traumatic synovitis and damaged articular cartilage

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041724A1 (en) * 2001-11-13 2003-05-22 Alcon, Inc. Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
J.Karlsson et al.Comparison of two hyaluronan drugs and placebo in patientswith knee osteoarthritis.A controlledk, randomized,double-blind,parallel-design multicentre study.Rheumatology41.2002,41第1241页左栏最后一段. *
宗田大.对膝痛的透明质酸制剂的注射疗法.诊断和治疗38 8.2001,38(8),第710页右栏第四段，第713页左栏第二段.
宗田大.对膝痛的透明质酸制剂的注射疗法.诊断和治疗38 8.2001,38(8),第710页右栏第四段,第713页左栏第二段. *
福岛等.对髂胫束炎的Artz的使用经验.药理和治疗（Jpn Pharmacol Ther）21 7.1993,21(7),第329页左栏第7-11行，右栏第6-8行、第331页左栏倒数第5-7行、第332页右栏倒数第2行至第333页左栏第1行.
福岛等.对髂胫束炎的Artz的使用经验.药理和治疗(Jpn Pharmacol Ther)21 7.1993,21(7),第329页左栏第7-11行,右栏第6-8行、第331页左栏倒数第5-7行、第332页右栏倒数第2行至第333页左栏第1行. *
罗瑞明.透明质酸（HA）的国内外研究现状.宁夏农学院学报22 1.2001,22(1),第62-64页.
罗瑞明.透明质酸(HA)的国内外研究现状.宁夏农学院学报22 1.2001,22(1),第62-64页. *
蒋丽霞等.透明质酸及其衍生物在医学上的应用.中国修复重建外科杂志14 5.2000,14(5),第315-318页.
蒋丽霞等.透明质酸及其衍生物在医学上的应用.中国修复重建外科杂志14 5.2000,14(5),第315-318页. *

Also Published As

Publication number Publication date
CN1859918A (zh) 2006-11-08
EP1677806A4 (en) 2007-04-04
CA2541813A1 (en) 2005-04-14
ES2317018T3 (es) 2009-04-16
JP2007507431A (ja) 2007-03-29
WO2005034965A1 (en) 2005-04-21
EP1677806B1 (en) 2008-11-19
JP2014205721A (ja) 2014-10-30
PT1677806E (pt) 2009-01-29
US20050080037A1 (en) 2005-04-14
AU2004277290A1 (en) 2005-04-14
CA2541813C (en) 2011-12-06
JP2016185989A (ja) 2016-10-27
AU2004277290B2 (en) 2010-05-13
JP2012236855A (ja) 2012-12-06
PL1677806T3 (pl) 2009-05-29
DE602004017888D1 (de) 2009-01-02
ATE414522T1 (de) 2008-12-15
WO2005032562A1 (en) 2005-04-14
SI1677806T1 (sl) 2009-06-30
DK1677806T3 (da) 2009-02-23
EP1677806A1 (en) 2006-07-12

Similar Documents

Publication Publication Date Title
JP2016185989A (ja) ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
JP4511031B2 (ja) 関節内注射用組成物及び注射可能水性組成物調合方法
Scale et al. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study
AU2010204445B2 (en) Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
JP6280628B2 (ja) 疼痛抑制用医薬組成物
JP2016540830A (ja) 水性カプサイシノイド配合物ならびに製造法および使用法
RU2433844C1 (ru) Способ лечения дегенеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических болевых синдромов
RU2299733C1 (ru) Способ лечения дегенеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических спаечных процессов
CN102665708B (zh) 用于治疗骨关节炎的组合
WO2018168921A1 (ja) 関節疾患処置用組成物およびこれを含むキット
CN120695028A (zh) 一种丁甘交联透明质酸钠凝胶及其组合物和制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20100707

CX01 Expiry of patent term